bioRxivBiochemistry
The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases
J. L. J. Coleman, T. Ngo, R. E. Smythe, A. J. Cleave, N. M. Jones, R. M. Graham, N. J. Smith
Abstract
GPR37L1 is an orphan G protein-coupled receptor expressed exclusively in the brain and linked to seizures, neuroprotection and cardiovascular disease. Based upon the observation that fragments of the GPR37L1 N-terminus are found in human cerebrospinal fluid, we hypothesized that GPR37L1 was subject to post-translational modification. Heterologous expression of GPR37L1-eYFP in either HEK293 or U87 glioblastoma cells yielded two cell surface species of approximately equivalent abundance, the larger of which is N-glycosylated at Asn105. The smaller species is produced by matrix metalloprotease/ADAM-mediated proteolysis (shown by the use of pharmacological inhibitors) and has a molecular weight identical to that of a mutant lacking the entire N-terminus, Δ122 GPR37L1. Serial truncation of the N-terminus prevented GPR37L1 expression except when the entire N-terminus was removed, narrowing the predicted site of N-terminal proteolysis to residues 105-122. Using yeast expressing different G protein chimeras, we found that wild type GPR37L1, but not Δ122 GPR37L1, coupled constitutively to Gpa1/Gαs and Gpa1/Gα16 chimeras, in contrast to previous studies. We tested the peptides identified in cerebrospinal fluid as well as their putative newly-generated N-terminal ‘tethered’ counterparts in both wild type and Δ122 GPR37L1 Gpa1/Gαs strains but saw no effect, suggesting that GPR37L1 does not signal in a manner akin to the protease-activated receptor family. We also saw no evidence of receptor activation or regulation by the reported GPR37L1 ligand, prosaptide/TX14A. Finally, the proteolytically processed species predominated both in vivo and ex vivo in organotypic cerebellar slice preparations, suggesting that GPR37L1 is rapidly processed to a signaling-inactive form. Our data indicate that the function of GPR37L1 in vivo is tightly regulated by metalloprotease-dependent N-terminal cleavage.Competing Interest StatementThe authors have declared no competing interest.View Full Text
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dissociation of the intramolecularly cleaved N- and C-terminal fragments of the adhesion G protein-coupled receptor GPR133 (ADGRD1) increases canonical signaling
J. D. Frenster, G. Stephan, … D. G. Placantonakis·bioRxiv·Dec 8, 2020
- Activation of the adhesion GPCR GPR133 (ADGRD1) by antibodies targeting the N-terminus
G. Stephan, J. D. Frenster, … D. G. Placantonakis·bioRxiv·Sep 13, 2021
- PTK7 is a positive allosteric modulator of GPR133 (ADGRD1) signaling in GBM
J. D. Frenster, H. Erdjument-Bromage, … D. G. Placantonakis·bioRxiv·Jun 15, 2022
- Satellite glial GPR37L1 regulates maresin and potassium channel signaling for pain control
Sangsu Bang, Changyu Jiang, … Ru‐Rong Ji·bioRxiv·Dec 3, 2023
- The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms
D. L. H. Bui, A. Roach, … R. Sando·bioRxiv·Apr 2, 2023
- Modulation of GPR133 (ADGRD1) Signaling by its Intracellular Interaction Partner Extended Synaptotagmin 1 (ESYT1)
G. Stephan, W. Liu, … D. Placantonakis·bioRxiv·Feb 9, 2023